Paper For Above instruction
Blood transfusions play a vital role in healthcare, especially in cases where patients experience significant blood loss or hematological deficiencies. The primary components transfused include packed red blood cells (PRBCs), plasma, and platelets, each serving distinct physiological purposes based on the patient's needs. PRBC transfusions are typically administered to treat anemia, characterized by a reduction in red blood cell count or hemoglobin levels, leading to decreased oxygen-carrying capacity. For instance, in patients with severe anemia due to blood loss or chronic disease, PRBCs help restore oxygen delivery to tissues. Plasma transfusions are often used to replenish coagulation factors in cases of bleeding disorders or liver failure, as plasma contains essential proteins responsible for blood clotting. Platelet transfusions are critical in patients experiencing thrombocytopenia or platelet dysfunction, such as those undergoing chemotherapy or with hematologic diseases, to prevent or control bleeding episodes (McCance & Huether, 2019). Understanding blood anatomy and physiology is fundamental to comprehending these transfusions’ importance, as it underscores how each blood component plays a specific role in maintaining homeostasis and facilitating recovery.
In the context of blood oxygenation, a pulse oximetry reading in the high 80s is slightly below the normal range of 95% to 100%. This indicates a mild hypoxemia, which may be expected in certain clinical scenarios such as anemia or respiratory compromise. For example, in anemia, the reduced hemoglobin concentration impairs oxygen transportation despite adequate lung function. Therefore, a patient with anemia may exhibit a pulse oximetry reading in the high 80s, reflecting decreased oxygen saturation. It is essential, however, to interpret pulse oximetry in conjunction with other clinical assessments and laboratory tests to identify the underlying cause of hypoxemia (Peters et al., 2017).
A case involving Mike, a 29-year-old male, presenting with weakness, hypotension, and recent spider bite

indicates a potentially critical condition. His symptoms, including oozing blood, moderate respiratory distress, jaundice, cool skin, tachycardia, hypotension, and low pulse oximetry, suggest a diagnosis of systemic envenomation leading to disseminated intravascular coagulation (DIC). The spider bite might have introduced venom causing hemolysis, coagulopathy, and vascular damage. Diagnostic tests such as complete blood count (CBC) to assess hemoglobin and platelet levels, coagulation profile including prothrombin time (PT), activated partial thromboplastin time (aPTT), and fibrinogen levels would be ordered to evaluate clotting status. Additionally, blood smear microscopy could reveal hemolytic activity, and serum bilirubin levels would indicate hemolysis severity. Treatment initially involves stabilizing the patient with fluid resuscitation, blood products (PRBCs, platelets, fresh frozen plasma), and antivenom if appropriate. Supportive care, including oxygen therapy and monitoring vital signs, is crucial.
During natural disasters like hurricanes, living in shelters amplifies the risk of infectious disease outbreaks, particularly tuberculosis (TB). The close quarters, overcrowding, limited ventilation, and compromised hygiene facilitate TB transmission via aerosolized droplets from coughing or sneezing. Drug-resistant tuberculosis has spread in such scenarios partly due to incomplete or inconsistent treatment regimens, patient non-adherence to medication, and the emergence of strains resistant to first-line anti-tubercular drugs. These resistant strains complicate treatment, requiring longer, more toxic, and costly second-line medications (World Health Organization [WHO], 2020). The resurgence of multidrug-resistant TB (MDR-TB) and extensively drug-resistant TB (XDR-TB) underscores the need for robust public health responses, including targeted screening, ensuring treatment adherence, and infection control measures during disaster recovery efforts.
Mary’s positive tuberculin skin test (TST) indicates prior exposure to Mycobacterium tuberculosis and suggests TB infection, but it does not confirm active disease. The result could represent latent TB infection, where the bacteria are contained by the immune system without causing symptoms or illness. Further diagnostic evaluation, such as a chest radiograph, sputum smear microscopy, or nucleic acid amplification tests (NAAT), is necessary to distinguish latent infection from active TB disease (Leung et al., 2017). A positive skin test indicates immune sensitization but must be correlated clinically and diagnostically to confirm active disease, which requires evidence of clinical symptoms like persistent cough, weight loss, fever, or radiographic findings.
Differentiating between a common cold and influenza based on symptoms involves analyzing presentation patterns. Both illnesses are respiratory infections caused by viruses; however, influenza tends to be more
severe with rapid onset, high fever, profound fatigue, muscle pains, and sometimes gastrointestinal symptoms. The common cold generally presents with milder symptoms such as nasal congestion, sore throat, sneezing, and mild fatigue, with less systemic involvement (Mayo Clinic, 2022). The abrupt onset of high fever and severe body aches are more characteristic of influenza, whereas a gradual onset with predominant nasal symptoms suggests a common cold.
Pneumonia, an infection of the lung parenchyma, can be caused by bacteria, viruses, fungi, or aspirated materials. The most common bacterial pathogen is Streptococcus pneumoniae, which leads to symptoms such as cough with purulent sputum, chest pain, fever, chills, and dyspnea. Viral pneumonia, caused by influenza or respiratory syncytial virus (RSV), often presents with fever, cough, and shortness of breath, with potential for rapid progression in vulnerable populations. Factors like smoking, immunosuppression, and chronic illnesses increase pneumonia risk. Treatment varies according to etiology; bacterial pneumonia generally requires antibiotics, while viral pneumonia may involve antiviral agents or supportive care. Preventive strategies include vaccination with pneumococcal and influenza vaccines, which are the most effective measures to reduce incidence and severity. Good hygiene practices, smoking cessation, and prompt treatment of respiratory infections also help prevent pneumonia and influenza (Mayo Clinic, 2022; Centers for Disease Control and Prevention [CDC], 2021).
In conclusion, understanding the specific functions of blood components underscores the importance of appropriate blood transfusions in various clinical conditions. Recognizing subtle signs such as pulse oximetry readings helps healthcare professionals assess patients’ oxygenation status. Rapid diagnosis and treatment of conditions like envenomation, coagulopathy, and infectious diseases are critical for patient outcomes, particularly during widespread emergencies like natural disasters where disease control becomes more challenging. Preventive measures, vaccination, and public health initiatives are vital in controlling infectious diseases such as tuberculosis, influenza, and pneumonia, emphasizing the need for continued education, research, and health infrastructure development to improve disease management and prevention.
References
Centers for Disease Control and Prevention. (2021). Pneumonia. https://www.cdc.gov/pneumococcal/about/all-about-pneumococcal.html
Leung, C. C., Zhau, C., & Mistry, S. (2017). Tuberculosis diagnosis and management. The Medical
Journal of Australia, 207(4), 165-170.
Mayo Clinic. (2022). Cold vs. flu: How to tell the difference. https://www.mayoclinic.org/diseases-conditions/common-cold/in-depth/cold-vs-flu/art-20465486
McCance, K. L., & Huether, S. E. (2019). Pathophysiology: The biologic basis for disease in adults and children (8th ed.). Elsevier.
Peters, M. F., et al. (2017). Pulse oximetry in clinical practice. Advances in Experimental Medicine and Biology, 979, 89–94.
World Health Organization. (2020). Global tuberculosis report 2020. https://www.who.int/publications/i/item/9789240013131